Arkolith/Insider Trading/NLTX/Form 4

Smith Sean Michael

Interim CFO, Prin Acct OffNeoleukin Therapeutics, Inc. (NLTX) · full profile →Form 4 · filed Aug 14, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$820
Net Open-Market Flow
-$820
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 11, 2023Sell(S)1K$0.62$82022K
Aug 10, 2023Option exercise(M)5K—$023K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 10, 2023Option exercise(M)5K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-045611) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML